236 related articles for article (PubMed ID: 18246127)
1. Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
Boisvert-Adamo K; Aplin AE
Oncogene; 2008 May; 27(23):3301-12. PubMed ID: 18246127
[TBL] [Abstract][Full Text] [Related]
2. Mcl-1 is required for melanoma cell resistance to anoikis.
Boisvert-Adamo K; Longmate W; Abel EV; Aplin AE
Mol Cancer Res; 2009 Apr; 7(4):549-56. PubMed ID: 19372583
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim.
Sheridan C; Brumatti G; Martin SJ
J Biol Chem; 2008 Aug; 283(32):22128-35. PubMed ID: 18508762
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
[TBL] [Abstract][Full Text] [Related]
5. Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.
Shao Y; Aplin AE
Cancer Res; 2010 Aug; 70(16):6670-81. PubMed ID: 20647317
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.
Jiang CC; Lai F; Tay KH; Croft A; Rizos H; Becker TM; Yang F; Liu H; Thorne RF; Hersey P; Zhang XD
Cell Death Dis; 2010 Sep; 1(9):e69. PubMed ID: 21364673
[TBL] [Abstract][Full Text] [Related]
7. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.
Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U
Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
[TBL] [Abstract][Full Text] [Related]
9. Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.
Cragg MS; Jansen ES; Cook M; Harris C; Strasser A; Scott CL
J Clin Invest; 2008 Nov; 118(11):3651-9. PubMed ID: 18949058
[TBL] [Abstract][Full Text] [Related]
10. The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism.
Zaanan A; Okamoto K; Kawakami H; Khazaie K; Huang S; Sinicrope FA
J Biol Chem; 2015 Sep; 290(39):23838-49. PubMed ID: 26245900
[TBL] [Abstract][Full Text] [Related]
11. Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells.
Goldstein NB; Johannes WU; Gadeliya AV; Green MR; Fujita M; Norris DA; Shellman YG
J Invest Dermatol; 2009 Feb; 129(2):432-7. PubMed ID: 18668139
[TBL] [Abstract][Full Text] [Related]
12. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells.
Greenhough A; Wallam CA; Hicks DJ; Moorghen M; Williams AC; Paraskeva C
Oncogene; 2010 Jun; 29(23):3398-410. PubMed ID: 20348947
[TBL] [Abstract][Full Text] [Related]
13. Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma.
Ekert PG; Jabbour AM; Manoharan A; Heraud JE; Yu J; Pakusch M; Michalak EM; Kelly PN; Callus B; Kiefer T; Verhagen A; Silke J; Strasser A; Borner C; Vaux DL
Blood; 2006 Sep; 108(5):1461-8. PubMed ID: 16705087
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
[TBL] [Abstract][Full Text] [Related]
15. BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma.
Shao Y; Aplin AE
Cell Death Differ; 2012 Dec; 19(12):2029-39. PubMed ID: 22858545
[TBL] [Abstract][Full Text] [Related]
16. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
Craxton A; Draves KE; Gruppi A; Clark EA
J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
[TBL] [Abstract][Full Text] [Related]
17. B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.
Boisvert-Adamo K; Aplin AE
Oncogene; 2006 Aug; 25(35):4848-56. PubMed ID: 16547495
[TBL] [Abstract][Full Text] [Related]
18. The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways.
Rahmani M; Anderson A; Habibi JR; Crabtree TR; Mayo M; Harada H; Ferreira-Gonzalez A; Dent P; Grant S
Blood; 2009 Nov; 114(20):4507-16. PubMed ID: 19773546
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Bim enhances replication of varicella-zoster virus and delays plaque formation in virus-infected cells.
Liu X; Cohen JI
J Virol; 2014 Jan; 88(2):1381-8. PubMed ID: 24227856
[TBL] [Abstract][Full Text] [Related]
20. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]